Ikarian Capital’s Protara Therapeutics TARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-350,489
| Closed | -$1.85M | – | 169 |
|
|
2024
Q4 | $1.85M | Buy |
350,489
+194,777
| +125% | +$1.03M | 0.25% | 49 |
|
|
2024
Q3 | $285K | Sell |
155,712
-25,000
| -14% | -$45.8K | 0.04% | 84 |
|
|
2024
Q2 | $376K | Sell |
180,712
-21,989
| -11% | -$45.7K | 0.07% | 74 |
|
|
2024
Q1 | $813K | Buy |
202,701
+14,037
| +7% | +$56.3K | 0.09% | 61 |
|
|
2023
Q4 | $353K | Hold |
188,664
| – | – | 0.03% | 67 |
|
|
2023
Q3 | $315K | Hold |
188,664
| – | – | 0.04% | 63 |
|
|
2023
Q2 | $451K | Hold |
188,664
| – | – | 0.07% | 61 |
|
|
2023
Q1 | $585K | Hold |
188,664
| – | – | 0.13% | 67 |
|
|
2022
Q4 | $506K | Hold |
188,664
| – | – | 0.12% | 43 |
|
|
2022
Q3 | $558K | Sell |
188,664
-69,189
| -27% | -$205K | 0.11% | 45 |
|
|
2022
Q2 | $756K | Sell |
257,853
-38,573
| -13% | -$113K | 0.14% | 54 |
|
|
2022
Q1 | $1.52M | Buy |
296,426
+17,170
| +6% | +$87.8K | 0.2% | 51 |
|
|
2021
Q4 | $1.89M | Sell |
279,256
-200,739
| -42% | -$1.36M | 0.28% | 42 |
|
|
2021
Q3 | $3.32M | Sell |
479,995
-104,809
| -18% | -$725K | 0.23% | 45 |
|
|
2021
Q2 | $5.7M | Sell |
584,804
-64,738
| -10% | -$631K | 0.46% | 26 |
|
|
2021
Q1 | $10.2M | Hold |
649,542
| – | – | 0.34% | 15 |
|
|
2020
Q4 | $15.7M | Sell |
649,542
-72,901
| -10% | -$1.76M | 0.69% | 6 |
|
|
2020
Q3 | $12.2M | Buy |
722,443
+194,479
| +37% | +$3.27M | 0.88% | 5 |
|
|
2020
Q2 | $15.5M | Buy |
527,964
+77,192
| +17% | +$2.26M | 1.23% | 4 |
|
|
2020
Q1 | $10.4M | Buy |
450,772
+442,363
| +5,261% | +$10.2M | 0.78% | 6 |
|
|
2019
Q4 | $138K | Buy |
+8,409
| New | +$138K | 0.02% | 42 |
|